Jfri A, Meltzer R, Guggina L. Runner Up: Incidence of Cutaneous Adverse Events with PI3K-Akt-mTOR Pathway Inhibitors: A Systematic Review and Network Meta-Analysis. J of Skin [Internet]. 2022 May 6 [cited 2024 Jul. 1];6(3):s39. Available from: https://jofskin.org/33014/index.php/skin/article/view/1580